1	Interleukin-1	Interleukin-1	B-NP	NN	B-protein	2	NMOD	0
2	receptor	receptor	I-NP	NN	I-protein	3	NMOD	0
3	antagonist	antagonist	I-NP	NN	O	4	SUB	0
4	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	18	inhibits
5	ischaemic	ischaemic	B-NP	JJ	O	7	AMOD	0
6	and	and	I-NP	CC	O	7	AMOD	0
7	excitotoxic	excitotoxic	I-NP	JJ	O	9	NMOD	0
8	neuronal	neuronal	I-NP	JJ	O	9	NMOD	0
9	damage	damage	I-NP	NN	O	4	OBJ	6	damage
10	in	in	B-PP	IN	O	4	VMOD	0
11	the	the	B-NP	DT	O	12	NMOD	0
12	rat	rat	I-NP	NN	O	10	PMOD	0
13	.	.	O	.	O	4	P	0

1	Interleukin-1	Interleukin-1	B-NP	NN	B-protein	5	NMOD	0
2	(	(	O	(	O	4	DEP	0
3	IL-1	IL-1	B-NP	NN	B-protein	4	DEP	0
4	)	)	O	)	O	1	NMOD	0
5	synthesis	synthesis	B-NP	NN	O	9	SUB	9	synthesis
6	in	in	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	8	NMOD	0
8	brain	brain	I-NP	NN	O	6	PMOD	0
9	is	be	B-VP	VBZ	O	0	ROOT	0
10	stimulated	stimulate	I-VP	VBN	O	9	VC	17	stimulated
11	by	by	B-PP	IN	O	10	VMOD	0
12	mechanical	mechanical	B-NP	JJ	O	13	NMOD	0
13	injury	injury	I-NP	NN	O	16	NMOD	0
14	and	and	I-NP	CC	O	16	NMOD	0
15	IL-1	IL-1	I-NP	NN	B-protein	16	NMOD	0
16	mimics	mimic	I-NP	NNS	O	18	NMOD	0
17	some	some	B-NP	DT	O	18	NMOD	0
18	effects	effect	I-NP	NNS	O	11	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	injury	injury	B-NP	NN	O	19	PMOD	0
21	,	,	O	,	O	18	P	0
22	such	such	B-PP	JJ	O	23	PMOD	0
23	as	as	I-PP	IN	O	18	NMOD	0
24	gliosis	gliosis	B-NP	NN	O	26	NMOD	0
25	and	and	I-NP	CC	O	26	NMOD	0
26	neovascularization	neovascularization	I-NP	NN	O	23	PMOD	3	neovascularization
27	.	.	O	.	O	9	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	report	report	B-VP	VBP	O	0	ROOT	0
3	that	that	B-SBAR	IN	O	2	VMOD	0
4	neuronal	neuronal	B-NP	JJ	O	5	NMOD	0
5	death	death	I-NP	NN	O	20	SUB	5	death
6	resulting	result	B-VP	VBG	O	5	NMOD	0
7	from	from	B-PP	IN	O	6	VMOD	0
8	focal	focal	B-NP	JJ	O	10	NMOD	0
9	cerebral	cerebral	I-NP	JJ	O	10	NMOD	0
10	ischaemia	ischaemia	I-NP	NN	O	7	PMOD	0
11	(	(	O	(	O	19	DEP	0
12	middle	middle	B-NP	JJ	O	15	NMOD	0
13	cerebral	cerebral	I-NP	JJ	O	15	NMOD	0
14	artery	artery	I-NP	NN	O	15	NMOD	0
15	occlusion	occlusion	I-NP	NN	O	18	NMOD	0
16	,	,	O	,	O	18	P	0
17	24	24	B-NP	CD	O	18	NMOD	0
18	h	h	I-NP	NN	O	19	DEP	0
19	)	)	O	)	O	10	NMOD	0
20	is	be	B-VP	VBZ	O	3	SBAR	0
21	significantly	significantly	I-VP	RB	O	20	VMOD	0
22	inhibited	inhibit	I-VP	VBN	O	20	VC	18	inhibited
23	(	(	O	(	O	22	VMOD	0
24	by	by	B-PP	IN	O	22	VMOD	0
25	50	50	B-NP	CD	O	26	NMOD	0
26	%	%	I-NP	NN	O	24	PMOD	0
27	)	)	O	)	O	22	VMOD	0
28	in	in	B-PP	IN	O	22	VMOD	0
29	rats	rat	B-NP	NNS	O	28	PMOD	0
30	injected	inject	B-VP	VBN	O	29	NMOD	19	injected
31	with	with	B-PP	IN	O	30	VMOD	0
32	a	a	B-NP	DT	O	36	NMOD	0
33	recombinant	recombinant	I-NP	JJ	O	36	NMOD	0
34	IL-1	IL-1	I-NP	NN	O	36	NMOD	0
35	receptor	receptor	I-NP	NN	O	36	NMOD	0
36	antagonist	antagonist	I-NP	NN	O	31	PMOD	0
37	(	(	O	(	O	36	NMOD	0
38	IL-1ra	IL-1ra	B-NP	NN	B-protein	45	NMOD	0
39	,	,	O	,	O	45	P	0
40	10	10	B-NP	CD	O	41	NMOD	0
41	micrograms	microgram	I-NP	NNS	O	45	NMOD	0
42	,	,	O	,	O	45	P	0
43	icv	icv	B-NP	NN	O	45	NMOD	0
44	30	30	I-NP	CD	O	45	NMOD	0
45	min	min	I-NP	NN	O	37	PMOD	0
46	before	before	B-PP	IN	O	45	NMOD	0
47	and	and	O	CC	O	46	PMOD	0
48	10	10	B-NP	CD	O	49	NMOD	0
49	min	min	I-NP	NN	O	46	PMOD	0
50	after	after	B-PP	IN	O	49	NMOD	0
51	ischaemia	ischaemia	B-NP	NN	O	50	PMOD	0
52	)	)	O	)	O	49	NMOD	0
53	.	.	O	.	O	2	P	0

1	Excitotoxic	Excitotoxic	B-NP	JJ	O	2	NMOD	0
2	damage	damage	I-NP	NN	O	16	SUB	0
3	due	due	B-PP	JJ	O	2	NMOD	0
4	to	to	B-PP	TO	O	3	AMOD	0
5	striatal	striatal	B-NP	JJ	O	6	NMOD	0
6	infusion	infusion	I-NP	NN	O	4	PMOD	19	infusion
7	of	of	B-PP	IN	O	6	NMOD	0
8	an	an	B-NP	DT	O	10	NMOD	0
9	NMDA-receptor	NMDA-receptor	I-NP	NN	O	10	NMOD	0
10	agonist	agonist	I-NP	NN	O	7	PMOD	0
11	(	(	O	(	O	15	DEP	0
12	cis-2	cis-2	B-NP	NN	B-DNA	14	NMOD	0
13	,	,	O	,	O	14	P	0
14	4-methanoglutamate	4-methanoglutamate	B-NP	NN	O	15	DEP	0
15	)	)	O	)	O	10	NMOD	0
16	was	be	B-VP	VBD	O	0	ROOT	0
17	also	also	I-VP	RB	O	16	VMOD	0
18	markedly	markedly	I-VP	RB	O	16	VMOD	0
19	inhibited	inhibit	I-VP	VBD	O	16	VC	0
20	(	(	O	(	O	23	DEP	0
21	71	71	B-NP	CD	O	22	NMOD	0
22	%	%	I-NP	NN	O	23	DEP	0
23	)	)	O	)	O	19	VMOD	0
24	by	by	B-PP	IN	O	19	VMOD	0
25	injection	injection	B-NP	NN	O	24	PMOD	19	injection
26	of	of	B-PP	IN	O	25	NMOD	0
27	the	the	B-NP	DT	O	28	NMOD	0
28	IL-1ra	IL-1ra	I-NP	NN	B-protein	26	PMOD	0
29	.	.	O	.	O	16	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	data	datum	I-NP	NNS	O	3	SUB	0
3	indicate	indicate	B-VP	VBP	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	18	DEP	0
5	endogenous	endogenous	B-NP	JJ	O	6	NMOD	0
6	IL-1	IL-1	I-NP	NN	B-protein	7	SUB	0
7	is	be	B-VP	VBZ	O	4	SBAR	0
8	a	a	B-NP	DT	O	9	NMOD	0
9	mediator	mediator	I-NP	NN	O	7	PRD	17	mediator
10	of	of	B-PP	IN	O	9	NMOD	0
11	ischaemic	ischaemic	B-NP	JJ	O	13	AMOD	0
12	and	and	I-NP	CC	O	13	AMOD	0
13	excitotoxic	excitotoxic	I-NP	JJ	O	15	NMOD	0
14	brain	brain	I-NP	NN	O	15	NMOD	0
15	damage	damage	I-NP	NN	O	10	PMOD	6	damage
16	,	,	O	,	O	18	P	0
17	and	and	O	CC	O	18	DEP	0
18	that	that	B-SBAR	IN	O	3	VMOD	0
19	inhibitors	inhibitor	B-NP	NNS	O	23	SUB	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	IL-1	IL-1	B-NP	NN	B-protein	22	NMOD	0
22	action	action	I-NP	NN	O	20	PMOD	0
23	may	may	B-VP	MD	O	18	SBAR	0
24	be	be	I-VP	VB	O	23	VC	0
25	of	of	B-PP	IN	O	24	PRD	0
26	therapeutic	therapeutic	B-NP	JJ	O	27	NMOD	0
27	value	value	I-NP	NN	O	25	PMOD	0
28	in	in	B-PP	IN	O	24	VMOD	0
29	the	the	B-NP	DT	O	30	NMOD	0
30	treatment	treatment	I-NP	NN	O	28	PMOD	0
31	of	of	B-PP	IN	O	30	NMOD	0
32	acute	acute	B-NP	JJ	O	36	NMOD	0
33	or	or	I-NP	CC	O	36	NMOD	0
34	chronic	chronic	I-NP	JJ	O	36	NMOD	0
35	neuronal	neuronal	I-NP	JJ	O	36	NMOD	0
36	death	death	I-NP	NN	O	31	PMOD	5	death
37	.	.	O	.	O	3	P	0

